Search results
Moderna (MRNA) Reports Q1 Loss, Tops Revenue Estimates
Zacks via Yahoo Finance· 4 hours agoModerna (MRNA) delivered earnings and revenue surprises of 14.48% and 33.88%, respectively, for the...
Moderna Stock Jumps After Scoring an Earnings Beat. Next Up? Its RSV Shot.
Barrons.com· 1 hour agoModerna reported first-quarter financial results Thursday that soundly beat Wall Street...
Moderna Puts Up Big Quarterly Beat; Could Shares Notch A Breakout?
Investor's Business Daily· 5 hours agoModerna beat Wall Street's first-quarter expectations Thursday. The news could bolster Moderna stock...
Moderna Stock Rises on Vaccine Launch Target, Above-Consensus 1Q
Market Watch· 2 hours agoBy Dean Seal Shares of Moderna rose after the company set a fall target date for the launch of its next vaccine and posted better first-quarter results than...
Moderna, Carvana and Peloton rise premarket; DoorDash, Fastly, Zillow fall By Investing.com
Investing.com· 4 hours agoModerna, Carvana and Peloton rise premarket; DoorDash, Fastly, Zillow fall
These Stocks Are Moving the Most Today: Carvana, Fastly, Peloton, Wayfair, Qualcomm, Moderna,...
Barrons.com· 1 hour agoCarvana posts a surprise first-quarter profit, Fastly stock sinks after the company issues guidance...
Moderna Q1 earnings: lower-than-expected loss of $1.18 billion sets tone for vaccine launch | Invezz
Invezz· 5 hours agoModerna Inc (NASDAQ: MRNA) reported a narrower-than-expected loss for the first quarter of the year,...
Stocks Halt Slide as Apple Climbs Before Earnings: Markets Wrap
Bloomberg via Yahoo Finance· 1 hour ago(Bloomberg) -- The world’s biggest technology companies drove a rebound in US stocks ahead of Apple...
Should You Buy Moderna Before May 12?
Motley Fool via Yahoo Finance· 6 days agoModerna (NASDAQ: MRNA) stock soared earlier in the pandemic as the company developed its coronavirus vaccine and the product went on to generate billions...
Why Earnings Season Could Be Great for Moderna (MRNA)
Zacks via Yahoo Finance· 1 day agoThis suggests that analysts have very recently bumped up their estimates for MRNA, giving the stock...